Diagnosis and Natural History of Genetic Conditions Across the Lifespan
Presentation is age-dependent
Genetic conditions present differently at different ages, and the same genotype may produce congenital anomalies, a childhood degenerative course, or adult-onset disease. Learn to distinguish screening from diagnostic testing, and to separate a diagnosis from a prognosis: natural history data drive surveillance intervals and anticipatory guidance.
Core concepts include pleiotropy, variable expressivity, reduced and age-dependent penetrance, anticipation (as in myotonic dystrophy and Huntington disease), locus and allelic heterogeneity, phenocopies, and somatic mosaicism. Newborn screening is a public health program that identifies presymptomatic infants and always requires confirmatory diagnostic testing. Predictive testing for adult-onset conditions follows distinct protocols and is generally deferred in minors when no childhood intervention exists.
Diagnosis across the lifespan means knowing when to suspect a condition in a fetus (structural anomalies, growth restriction), a neonate (hypotonia, feeding difficulty, ambiguous genitalia, metabolic crisis), a child (developmental delay, regression, seizures), and an adult (neurodegeneration, cardiomyopathy, cancer predisposition, infertility). Regression is a red flag for a neurodegenerative or metabolic process rather than a static encephalopathy.
Traps
Concluding that a negative family history excludes a dominant disorder, when de novo variants, reduced penetrance, small family size, and misattributed parentage all apply. Treating a screening result as diagnostic. Quoting a penetrance figure for a variant without considering the patient's age and sex. Missing a phenocopy, such as an acquired cardiomyopathy or environmental teratogen.
Rule of thumb
When the phenotype is progressive or involves multiple organ systems, ask whether the natural history is static, progressive, or episodic, because that answer determines both the differential and the surveillance plan.